BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33404783)

  • 21. [IgD myeloma with amyloidosis. Description of a case].
    Sánchez Rodríguez A; Sánchez Martín S; González Macías J; García Marcos MA; Díez Jarilla JL; de Castro del Pozo S
    Rev Clin Esp; 1981 May; 161(3):187-91. PubMed ID: 7268128
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation.
    Larsen CP; Bell JM; Harris AA; Messias NC; Wang YH; Walker PD
    Mod Pathol; 2011 Nov; 24(11):1462-9. PubMed ID: 21701535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
    CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
    Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
    Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma-associated cast nephropathy with crystal structure: case report and review of the literature.
    Chen KJ; Jan YJ; Chen CH; Cheng CH; Wu MJ; Shu KH
    Nephrology (Carlton); 2005 Dec; 10(6):594-6. PubMed ID: 16354243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light chain deposition disease involving kidney and liver in a patient with IgD myeloma.
    Tsushima T; Suzuki T; Terao T; Miura D; Narita K; Takeuchi M; Shimuzu A; Matsue K
    BMC Nephrol; 2021 Jan; 22(1):40. PubMed ID: 33485303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgD paraproteinemias.
    Tichý M; Matĕja F; Urban P; Matuska M
    Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic amyloidosis and multiple myeloma. Report of a case with the association of light chain myeloma and gastric plasmacytosis (author's transl)].
    Libeskind M; Malbran J; Lugagne F; Agard D; Gatineau-Saillant C; Guyet-Rousset P
    Gastroenterol Clin Biol; 1977 Mar; 1(3):267-74. PubMed ID: 408215
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma cell myeloma, hyperviscosity and amyloidosis associated with a serum IgG3 lambda and urinary excretion of two fragments related to the variable portion of lambda light chains.
    Isobe T; Takatsuki K; Tishendorf FW; Birken S; Osserman EF
    Clin Immunol Immunopathol; 1981 Apr; 19(1):55-66. PubMed ID: 6783356
    [No Abstract]   [Full Text] [Related]  

  • 32. Myeloma-related kidney disease.
    Leung N; Nasr SH
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):36-47. PubMed ID: 24359985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma-associated light chain amyloidosis presenting as verrucous lingual masses.
    Lee KH; Lee JS; Cho YK; Kim SY; Yoo JY; Park CJ
    Acta Derm Venereol; 2005; 85(5):447-8. PubMed ID: 16159741
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary immunologic features of alveolar septal amyloidosis associated with multiple myeloma.
    Morgan JE; McCaul DS; Rodriguez FH; Abernathy DA; deShazo RD; Banks DE
    Chest; 1987 Oct; 92(4):704-8. PubMed ID: 3115688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IgD myeloma. Report of 4 cases (author's transl)].
    Palau Beato E; Audibert Mena L; Ribera Casado JM; Ruiz de Aguiar A; Martínez Santos MP
    Sangre (Barc); 1981; 26(3):383-9. PubMed ID: 6794161
    [No Abstract]   [Full Text] [Related]  

  • 36. [Occurrence of two kinds of cancers in the course of IgG-lambda type myeloma with amyloidosis: report of a case (author's transl)].
    Morita T; Okada T; Ohga T; Kanoh T; Okada H
    Nihon Naika Gakkai Zasshi; 1979 Apr; 68(4):397-403. PubMed ID: 109552
    [No Abstract]   [Full Text] [Related]  

  • 37. Four cases of IgD multiple myeloma.
    Deam DR; Busmanis IA; Hussein S; Ratnaike S
    Pathology; 1991 Oct; 23(4):339-43. PubMed ID: 1784526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgD myeloma with systemic amyloidosis with chest discomfort as an initial symptom.
    Kizaki M; Ieda M; Satoh T; Awaya N; Hattori Y; Kumagai H; Hori S; Mori T; Rao H
    Keio J Med; 2004 Sep; 53(3):178-90. PubMed ID: 15477732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
    Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
    Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors in light chain amyloidosis].
    Jávorniczky NR; Bodó I; Masszi T; Mikala G
    Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.